Oxford vaccine shows 70 percent protection against coronary

This news represents triumph and frustration, as vaccines produced by Pfizer and Modern companies show 95 percent protection, broadcast the BBC.

Oxford's vaccine, however, has been said to be much cheaper, easier to preserve and more accessible in each corner of the world than in comparison with the other two.

If approved by regulators, it is believed it can play an important role in fighting pandemic.

Oxford researchers have conducted in 10 months, testing for vaccines usually conducted in a decade.

Today's version takes us a step closer to the time when we can use vaccines and end the destruction caused by virus”, said vaccine architect Sarah Gilbert.

The British government has so far ordered 100 million doses of Oxford vaccine, enough to immune 50 million people.